{"database": "lobbying", "table": "lobbying_activities", "rows": [[1919205, "098197d8-4607-40e3-a5ab-7a431b6fca7f", "Q4", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "ASTRAZENECA", 2016, "fourth_quarter", "PHA", "PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation \nH.R. 3204 - The Drug Quality and Security Act, implementation\nH.R. 6 - 21st Century Cures\nInnovation For Healthier Americans\nH.R. 34 - 21st Century Cures Act\n\n***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements, user fee sequester relief, Innovation", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2017-01-18T16:46:29-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1919205"], "units": {}, "query_ms": 62.39788793027401, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}